Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer CARR EDWARD
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Veness Adam M
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Randhawa Simrat
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Savitz Ryan
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Garcia Marino
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Violin Jonathan
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Soteropoulos Paula
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOULDER LEON O JR
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McGeorge Anne
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lawton Alison Frances
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Dianthus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(9.99%),Fairmount Healthcare Fund II LP(9.99%), etc.
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Andrew J. Schwab(5.7%),Kush Parmar(5.7%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Third Rock Ventures IV, L.P.(0%),Third Rock Ventures GP IV, L.P.(0%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(0.0%),Citadel Advisors Holdings LP(0.0%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GV 2016, L.P.(1.4%),GV 2016 GP, L.P.(1.4%), etc.
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BCLS Fund III Investments, LP(9.99%)
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Dianthus Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%), etc.
No Data